Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 3, 2018
GefitinibJustyna Rawluk, Cornelius F Waller
Onkologie|December 14, 2011
Does colorectal cancer in ulcerative colitis patients constitute a risk for chemotherapy refractoriness?:a systemic approach by detailed analysis via the electronic tumor base documentation systemMonika Engelhardt, Gabriele Ihorst, Josefina Udi, et al.
Lung Cancer (Amsterdam, Netherlands)|September 1, 2023
Immune checkpoint inhibitors in non-small cell lung cancer - When should we dare to stop treatment?Farastuk Bozorgmehr, Annette Müller, Justyna Rawluk, et al.
Scientific Reports|June 20, 2024
Low densities of immune cells indicate unfavourable overall survival in patients suffering from squamous cell carcinoma of the lungSimone Steffens, Claudia Kayser, Anuschka Roesner, et al.
Plos One|February 19, 2013
Simultaneous multi-antibody staining in non-small cell lung cancer strengthens diagnostic accuracy especially in small tissue samplesGian Kayser, Agnes Csanadi, Claudia Otto, et al.
Blood|May 21, 2005
Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cellsMeike Burger, Tanja Hartmann, Myriam Krome, et al.
Blood|October 21, 2006
Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arraysDietmar Pfeifer, Milena Pantic, Ilona Skatulla, et al.
Pathology|February 20, 2018
Overexpression of SLC1a5 in lymph node metastases outperforms assessment in the primary as a negative prognosticator in non-small cell lung cancerAgnes Csanadi, Annika Oser, Konrad Aumann, et al.
Anticancer Research|July 5, 2018
CC-Chemokine Ligand 18 Is an Independent Prognostic Marker in Lymph Node-positive Non-small Cell Lung CancerSeverin Schmid, Agnes Csanadi, Nikola Kozhuharov, et al.
Deutsche Medizinische Wochenschrift (1946)|January 31, 2019
[Management of adverse events in immune oncology - Practical aspects of immune-related adverse events during immune oncological treatment]Niels Reinmuth, Michael Bitzer, Barbara Deschler-Baier, et al.
Pageof 3